🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gerald Pierone

Oyster Point Family Health Center

ORCID: 0000-0003-0159-7243

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial”.

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis

The Lancet HIV(2025)10.1016/s2352-3018(25)00043-8

N/A

0.398DataRank · unranked

6 citations

Carlos Malvestutto, Maya Watanabe, Emma Smith, Heather J. Ribaudo, Sara McCallum +90 more

Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

Circulation Heart Failure(2025)10.1161/circheartfailure.125.013382

N/A

0DataRank · unranked

2 citations

Maya Watanabe, Sara McCallum, Judith A. Aberg, Aya Awwad, Thomas Campbell +17 more

Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real‐world evidence from the OPERA cohort

HIV Medicine(2025)10.1111/hiv.70105

N/A

0DataRank · unranked

0 citations

Laurence Brunet, Jennifer S Fusco, Michael Sension, Megan S. Dunbar, Joshua Gruber +3 more